Skip to content
Wednesday, October 28, 2026 Market moodNeutral+5.9
Sign in
GlideslopeGlideslopeGlideslope AI-powered market news
GlideslopeGlideslopeGlideslope
Market mood+5.9
Breaking
CNBC TOP STORIES Oracle stock pops 13% as long-term revenue forecast and clarity on financing ease debt co… Pessimistic THE VERGE Brendan Carr plans to let prisons jam cellphone signals Neutral MARKET WATCH Gen Z voters told us the midterms will boil down to affording life, not social issues Pessimistic BBC BUSINESS Five ways the Budget will affect you if you are under 25 Pessimistic FOX NEWS US FBI reports 67% jump in violent crime arrests under Trump compared to Biden’s final months Optimistic CBS MONEY WATCH Fed holds interest rates steady even as inflation remains high Bullish THE VERGE Microsoft is ending Copilot support on smart TVs Bullish THE GUARDIAN US NEWS FDA scientists opposed Trump administration’s move to ease peptide access Neutral NEW YORK TIMES BUSINESS An ‘Endless’ Cruise Around the World Is Suspended, Leaving Passengers Stranded Neutral DEFENSE NEWS Inside MSI’s Next Generation of Counter-Drone Defense Neutral WIRED I Put a Bunch of AI Agents in Charge of a Fantasy Soccer Team. They’re Not Better Than Hu… Pessimistic MARKET WATCH I’m planning a trip to Europe. Is it dumb to take travel advice from influencers? Neutral FOREIGN POLICY Ukrainians Have a Long-Shot Plan to Boot Russia from the U.N. Pessimistic BUSINESS INSIDER Elizabeth Holmes' most famous photo started with a simple request from a photographer Neutral NEW YORK POST BUSINESS LA nightlife staple in trendy neighborhood begs for support as ‘dunzo’ rumors fly Bullish ROBOTICS & AUTOMATION The Payroll Challenges of Scaling Robotics Businesses Strong Bullish THE DAILY CALLER Hegseth Pushes New Asian Defense Framework As China Flexes Military Might Neutral ROBOTICS & AUTOMATION The Factory PCs Nobody Patches: Why Automation Needs Remote Monitoring Neutral WSJ ECONOMY The Fed held rates steady, but two officials dissented in favor of an increase, including… Bullish YOUTUBE - BRAVOS RESEARCH A $2 Trillion Stock Market Trap Is Being Set... Neutral CNBC TOP STORIES Oracle stock pops 13% as long-term revenue forecast and clarity on financing ease debt co… Pessimistic THE VERGE Brendan Carr plans to let prisons jam cellphone signals Neutral MARKET WATCH Gen Z voters told us the midterms will boil down to affording life, not social issues Pessimistic BBC BUSINESS Five ways the Budget will affect you if you are under 25 Pessimistic FOX NEWS US FBI reports 67% jump in violent crime arrests under Trump compared to Biden’s final months Optimistic CBS MONEY WATCH Fed holds interest rates steady even as inflation remains high Bullish THE VERGE Microsoft is ending Copilot support on smart TVs Bullish THE GUARDIAN US NEWS FDA scientists opposed Trump administration’s move to ease peptide access Neutral NEW YORK TIMES BUSINESS An ‘Endless’ Cruise Around the World Is Suspended, Leaving Passengers Stranded Neutral DEFENSE NEWS Inside MSI’s Next Generation of Counter-Drone Defense Neutral WIRED I Put a Bunch of AI Agents in Charge of a Fantasy Soccer Team. They’re Not Better Than Hu… Pessimistic MARKET WATCH I’m planning a trip to Europe. Is it dumb to take travel advice from influencers? Neutral FOREIGN POLICY Ukrainians Have a Long-Shot Plan to Boot Russia from the U.N. Pessimistic BUSINESS INSIDER Elizabeth Holmes' most famous photo started with a simple request from a photographer Neutral NEW YORK POST BUSINESS LA nightlife staple in trendy neighborhood begs for support as ‘dunzo’ rumors fly Bullish ROBOTICS & AUTOMATION The Payroll Challenges of Scaling Robotics Businesses Strong Bullish THE DAILY CALLER Hegseth Pushes New Asian Defense Framework As China Flexes Military Might Neutral ROBOTICS & AUTOMATION The Factory PCs Nobody Patches: Why Automation Needs Remote Monitoring Neutral WSJ ECONOMY The Fed held rates steady, but two officials dissented in favor of an increase, including… Bullish YOUTUBE - BRAVOS RESEARCH A $2 Trillion Stock Market Trap Is Being Set... Neutral
CNBC Top Stories · Oct 27, 2026 6:03 PM EDT Healthcare

I just bought this pharma stock for its next generation of blockbuster drugs — and its dividend

AbbVie is entering a new chapter of growth, fueled by its blockbuster immunology drugs and expanding neuroscience business. Investor Kevin Simpson shares why he's optimistic.

I just bought this pharma stock for its next generation of blockbuster drugs — and its dividend
Image CNBC Top Stories

AI brief

Pulse reads the full article
What happened
Why it matters
What to watch

Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.

Sign in to read the brief
● MACRO ANALYST

Apex+

Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.

LOG IN / SUBSCRIBE